Trending Now

Fortune Post Healthcare

Healthcare News

Menu
Follow Us:
Search
Flash Story
Private Equity Investments In Healthcare Raises Costs: Study
Private Equity Investments In Healthcare Raises Costs: Study
EU Regulator Declines To Support Mirati's Lung Cancer Drug
EU Regulator Declines To Support Mirati’s Lung Cancer Drug
HIV Drug Resistance Mechanisms Revealed By Protein Structures: Study
HIV Drug Resistance Mechanisms Revealed By Protein Structures: Study
Gambia To Explore Legal Action On Maiden Pharma Over Toxic Cough Syrup
Gambia To Explore Legal Action On Maiden Pharma Over Toxic Cough Syrup
Annual Profit Forecast Raised By J&J On Medical Devices, Cancer Drugs Strength
Annual Profit Forecast Raised By J&J On Medical Devices, Cancer Drugs Strength
Lupin Gets Tentative Approval From USFDA For Hepatitis Drugs & HIV
Lupin Gets Tentative Approval From USFDA For Hepatitis Drugs & HIV
WHO Warned On Dengue Risk For Global Warming Impact
WHO Warned On Dengue Risk For Global Warming Impact
Govt. Says Over 2 Lakh Calls Received On Tele-Manas Since Its Launch
Govt. Says Over 2 Lakh Calls Received On Tele-Manas Since Its Launch
Are You Consuming Enough Niacin? Add These Superfoods To Your Diet

Tag: lupin ltd

Healthcare
healthcare

Lupin Gets Tentative Approval From USFDA For Hepatitis Drugs & HIV

Lupin Gets Tentative Approval From USFDA For Hepatitis Drugs & HIV – Dolutegravir Lamivudine is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. Whereas Tenofovir alafenamide is a medication for the treatment of chronic hepatitis B virus in adults with compensated liver disease Indian pharma major Lupin on Friday said that it has […]

Back To Top